Skip to content

Studying on how medicines affect children with kidney problems benefits side effects and costs

Investigation of immunosuppressants therapy associated therapeutic outcomes toxicity outcomes and cost outcomes in paediatric patients with nephrotic syndrome - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095987
Enrollment
150
Registered
2025-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality

Interventions

Intervention1: Immunosuppressants: These medications are given to children aged 1-18 years who do not respond to or cannot tolerate steroid therapy. The research will monitor how well these drugs work

Sponsors

KLE college of pharmacy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Paediatric patients aged 1 to 18 years. Diagnosed with steroid resistant or steroid dependent nephrotic syndrome Patients who are currently receiving or planned to receive immunosuppressant Patients and guardians who provide written informed consent

Exclusion criteria

Exclusion criteria: Patient with secondary causes of nephrotic syndrome like lupus nephritis or infections or malignancy Known chronic liver disease or heart failure or any other severe systemic illness Parents guardians unwilling or unable to provide written informed consent

Design outcomes

Primary

MeasureTime frame
Remission rate and relapse frequency Incidence and severity of drug toxicity Cost comparison among immunosuppressantsTimepoint: after 15 days

Secondary

MeasureTime frame
Change in health related quality of life scores Validation and impact of the patient information leafletTimepoint: after 15 days

Countries

India

Contacts

Public ContactAnjalna Shaikh

KLE college of pharmacy

shashikalawali@klepharm.edu9902944602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026